Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Synta Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (20)	10/2/2007 7:08:40 AM
From: HMS88	Read Replies (1) \| Respond to of 112

Steve, I'm originally a New Yorker. I've been to Canada and from what I've seen, its a shame I wasn't born there. I'm especially fond of BC and Victoria but can say good things about Toronto and Montreal and Nova Scotia. I am a professional and as a student sat on a board with Judah Folkman. I am sure he is happy to participate on a commitee and the BODs because of the free options he gets in SNTA, but I think the fact that he is on the board means that this company is strategically poising itself to optimize its story for capital-raising purposes. Also the first phase 2 study on the melanoma drug looks might fine. That isn't predictive for phase 3, but at least there will be a phase 3 based on merit. Looks like I missed the boat today, with a low of 6.60. I wouldn't have pulled the trigger there and was looking for something more around 5.75 to 6.00. What's something of your interest and background? Andrew